247568-84-9

Upstream product

• 177545-89-0 (1r,4r)-4-((tert-butoxycarbonyl)amino)cyclohexyl methanesulfonate 
• 111300-06-2 trans-tert-butyl 4-hydroxycyclohexylcarbamate 

Downstream Products

• 247570-24-7 tert-butyl N-[(1s,4s)-4-aminocyclohexyl]carbamate 
• 920518-32-7 {cis-4-[4-(pyrrolidine-1-carbonyl)-[1,2,3]triazol-1-yl]-cyclohexyl}-carbamic acid tert-butyl ester 
• 920518-52-1 1-(cis-4-tert-butoxycarbonylamino-cyclohexyl)-1H-[1,2,3]triazole-4-carboxylic acid methyl ester 

Relevant academic research and scientific papers

SUBSTITUTED TRIAZOLE DERIVATIVES AND THEIR USE AS NEUROKININ 3 RECEPTOR ANTAGONISTS

The present invention relates to compounds of formula (I) wherein R1 is -(CRR')n-aryl-(CRR')n-heteroaryl, -(CRR')n-O-aryl or -(CRR')n-O-heteroaryl, wherein the aryl or heteroaryl groups are unsubstitu

Crystalline forms of cis-5-fluoro-N-?4-(2-hydroxy-4-methylbenzamido)cyclohexyl|-2-(tetrahydrothiopyran-4-yloxy)nicotinamide

The present invention relates to new crystalline forms of syn-5-Fluoro-N-[4-(2-hydroxy-4-methyl-benzoylamino)-cyclohexyl]-2-(tetrahydro-thiopyran-4-yloxy)-nicotinamide and to processes for the preparation of, compositions containing and the uses of such crystalline forms.

Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity

The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.